Cancer cells with thicker glycocalyx barrier are better at evading immune cells
American Society for Biochemistry and Molecular Biology (ASBMB)Researchers examined the material properties of a thin surface barrier called the glycocalyx with unprecedented resolution, revealing information that could help improve current cell-based cancer immunotherapies.